Facebook
X
LinkedIn
ForwardBreaking Issues in Opioid Use Disorder Treatment_LIVE
The goal of this continuing education program is to educate attendees on emerging therapeutic approaches for opioid use disorder (OUD) and barriers and facilitators regarding access to OUD treatment.
Program Schedule:
- 6:00pm: Welcome and Introductions
- Speaker: Lucas G. Hill, PharmD, FCCP, Associate Professor and Implementation and Research Center for Healthy Communities (IRC) Executive Director, University of Pittsburgh School of Pharmacy
- 6:05-6:55pm: Opioid Use Disorder: Emerging Therapeutic Considerations
- 7:00pm-7:50pm: Opioid Use Disorder: Challenges for Pharmacists
- 7:55pm: Session Wrap-Up
Target Audience
Pharmacist
Pharmacy technicians
Learning Objectives
By the end of this session, participants will be able to:
1. Compare the mechanism, efficacy, and safety of FDA-approved medications for OUD
2. Describe evidence-based buprenorphine initiation strategies
3. Explain updated approaches to long-acting injectable buprenorphine initiation
4. Identify barriers and facilitators to pharmacist dispensing of buprenorphine and provision of naloxone and syringes
5. Describe recent regulatory and policy changes affecting pharmacy-based OUD care 6. Apply evidence-based, non-stigmatizing practices to reduce dispensing delays and improve access to OUD treatment
6. Apply evidence-based, non-stigmatizing practices to reduce dispensing delays and improve access to OUD treatment
Additional Information
| Attachment | Size |
|---|---|
 Pitt Pharmacy Preceptor CE Fall 2026 Flyer.docx | 572.52 KB |
The goal of this continuing education program is to educate attendees on emerging therapeutic approaches for opioid use disorder (OUD) and barriers and facilitators regarding access to OUD treatment.
Program Schedule:
- 6:00pm: Welcome and Introductions
- Speaker: Lucas G. Hill, PharmD, FCCP, Associate Professor and Implementation and Research Center for Healthy Communities (IRC) Executive Director, University of Pittsburgh School of Pharmacy
- 6:05-6:55pm: Opioid Use Disorder: Emerging Therapeutic Considerations
- 7:00pm-7:50pm: Opioid Use Disorder: Challenges for Pharmacists
- 7:55pm: Session Wrap-Up
Lucas G. Hill, PharmD, FCCP, Associate Professor and Implementation and Research Center for Healthy Communities (IRC) Executive Director, University of Pittsburgh School of Pharmacy
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (ACPE)
The maximum number of hours awarded for this Continuing Pharmacy Education activity is 2.0 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 2.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 2.00 Attendance
Any questions regarding registration, zoom link or cancellations please contact Alison Zappa, [email protected]